718 related articles for article (PubMed ID: 29490558)
21. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
Voong KR; Rashid A; Crane CH; Minsky BD; Krishnan S; Yao JC; Wolff RA; Skibber JM; Feig BW; Chang GJ; Das P
Am J Clin Oncol; 2017 Dec; 40(6):555-560. PubMed ID: 26237193
[TBL] [Abstract][Full Text] [Related]
22. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
23. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
24. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
25. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
[TBL] [Abstract][Full Text] [Related]
26. [The therapeutic results and early and late toxicities of the treatment of anal canal carcinoma by radiotherapy or chemoradiotherapy].
Sommer K; Brockmann WP; Wiegel T; Krüll A; Hübener KH; Birk S
Strahlenther Onkol; 1991 Aug; 167(8):445-51. PubMed ID: 1909466
[TBL] [Abstract][Full Text] [Related]
27. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Dewas CV; Maingon P; Dalban C; Petitfils A; Peignaux K; Truc G; Martin E; Khoury C; Dewas S; Créhange G
Radiat Oncol; 2012 Nov; 7():201. PubMed ID: 23190693
[TBL] [Abstract][Full Text] [Related]
28. Survival Outcomes After Initial Treatment for Anal Adenocarcinoma: A Population-Based Cohort Study.
Park H
Clin Colorectal Cancer; 2020 Sep; 19(3):e75-e82. PubMed ID: 32389595
[TBL] [Abstract][Full Text] [Related]
29. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.
Kole AJ; Stahl JM; Park HS; Khan SA; Johung KL
J Natl Compr Canc Netw; 2017 Mar; 15(3):355-362. PubMed ID: 28275036
[No Abstract] [Full Text] [Related]
30. Aggressive treatment approach for cloacogenic carcinoma of the anorectum: report from a single cancer center.
Bertani E; Chiappa A; Mazzarol G; Contino G; Lazzari R; Zampino MG; Viale G; Andreoni B
Dig Surg; 2010; 27(4):297-301. PubMed ID: 20689291
[TBL] [Abstract][Full Text] [Related]
31. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I
Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768
[TBL] [Abstract][Full Text] [Related]
32. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
[TBL] [Abstract][Full Text] [Related]
33. Postoperative versus definitive chemoradiation in early-stage anal cancer. Results of a matched-pair analysis.
Berger B; Menzel M; Breucha G; Bamberg M; Weinmann M
Strahlenther Onkol; 2012 Jul; 188(7):558-63. PubMed ID: 22569957
[TBL] [Abstract][Full Text] [Related]
34. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
35. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
[TBL] [Abstract][Full Text] [Related]
36. Squamous cell carcinoma of the anal margin: the university of Florida experience.
Balamucki CJ; Zlotecki RA; Rout WR; Newlin HE; Morris CG; Kirwan JM; George TJ; Mendenhall WM
Am J Clin Oncol; 2011 Aug; 34(4):406-10. PubMed ID: 20881476
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
38. Patterns of recurrence in anal canal carcinoma.
Faynsod M; Vargas HI; Tolmos J; Udani VM; Dave S; Arnell T; Stabile BE; Stamos MJ
Arch Surg; 2000 Sep; 135(9):1090-3; discussion 1094-5. PubMed ID: 10982516
[TBL] [Abstract][Full Text] [Related]
39. Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective.
Kim KH; Chang JS; Cha JH; Lee IJ; Kim DJ; Cho BC; Park KR; Lee CG
Cancer Res Treat; 2017 Jan; 49(1):168-177. PubMed ID: 27338033
[TBL] [Abstract][Full Text] [Related]
40. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
